Elad Sharon, Medical Oncologist at Dana-Farber, shared his recent article on X:
“Incidentally, this is the fifth article to be published in The New England Journal of Medicine from a trial I oversaw or co-led while I was working at NCI CTEP Clinical Research.
Proud to be part of the team that brought together the AMBASSADOR trial from Alliance for Clinical Trials in Oncology and NCI CTEP Clinical Research.
We got this into the European Society for Medical Oncology and NEJM.
Incredible work led by Andrea B. Apolo of NCI Center for Cancer Research.”
Tittle:Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
Author: Andrea B. Apolo, Karla V. Ballman, Guru Sonpavde, Stephanie Berg, D.O, William Y. Kim, Rahul Parikh, Min Yuen Teo and Jonathan E. Rosenberg et al.
Source: Elad Sharon/X